Abstract
Despite public policy measures to prevent cancer, such as tobacco control and
vaccination against HPV, cancer is sure to remain a significant public health
problem throughout the 21st century. Indeed, the global demographic shift
towards an ageing population and the spread of high tech modern medicine
throughout the emerging economies of Asia and (maybe later) Africa, will
expand the market for cancer diagnostics globally. Major developments are
likely in both the IVD market and in imaging-based modalities, like computed
tomography, with the emphasis being upon the personalized medicine approach,
where demand will come from physicians, patients and payors - all of whom
want more effective treatments and value for money. ' Innovations in Oncology
Diagnostics' is a new report published by Business Insights that analyzes the
latest innovations in oncology diagnostics and identifies the most exciting
new technologies and trends, ranging from body imaging and cytology to
molecular diagnostics and pharmacogenomics. This report also identifies the
key challenges facing innovative diagnostics companies.
| 
View Cart
